SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is trending as users compare it to other high-growth cryptos like $HYPE.X, with some anticipating significant gains and highlighting its strong backing. The community is actively discussing its potential to reach new price levels, fueled by its recent listing and perceived undervaluation, while also comparing it to similar projects.

DePhyneAI is a decentralized physical AI infrastructure enabling autonomous devices such as drones, robots, and edge sensors to perform intelligent tasks while earning rewards in the native token, $DPHY. The network is permissionless, community-owned, and designed to bring scalable, secure AI computation to the edge of the real world.  1. Introduction Artificial Intelligence has historically been confined to centralized cloud platforms. However, as physical devices grow more capable, the future lies in enabling intelligence directly on the edge - embedded in the real world. DePhyneAI empowers a decentralized network of autonomous agents to train, infer, and collaborate - creating a self-sustaining AI ecosystem governed by a native token economy.  What is DePhyneAI? DePhyneAI is an open, decentralized network where physical devices act as nodes. Each device contributes compute, data, or services and is rewarded in $DPHY tokens. The network supports:  Federated learning and on-device AI inference Secure blockchain-based coordination Real-time decision-making in physical environments Use Cases DePhyneAI supports diverse real-world applications:  Logistics: AI-enabled autonomous drone deliveries Agriculture: Monitoring soil, crop health, irrigation using robotic systems Smart Cities: Surveillance, traffic analysis, energy optimization Disaster Response: Real-time aerial monitoring and situational AI Why $DPHY Matters The $DPHY token is the lifeblood of the DePhyneAI network. It serves multiple purposes:  Rewards: Earned by node operators who run AI tasks Access: Used to access AI models, data feeds, and services Governance: Voting and proposal mechanisms Staking: Ensures quality and uptime guarantees

DePhyneAI

DePhyneAI ($DPHYAI.X) is trending as part of the AI crypto wave, with community members actively discussing its potential within the Phantom wallet ecosystem. Some users are highlighting its microcap status and potential for growth, while others urge caution, referencing previous hyped tokens. The focus remains on $DPHYAI.X's role in the broader AI narrative within the crypto space.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is trending as the community rallies behind its potential as the leading AI dog coin, drawing inspiration from xAI's Grok. Discussions highlight its community-driven nature, zero-tax policy, burned liquidity, and potential for significant growth in the meme coin space.

Tether (USDT) is a cryptocurrency with a value meant to mirror the value of the U.S. dollar. The idea was to create a stable cryptocurrency that can be used like digital dollars. Coins that serve this purpose of being a stable dollar substitute are called “stable coins.” Tether is the most popular stable coin and even acts as a dollar replacement on many popular exchanges! According to their site, Tether converts cash into digital currency, to anchor or “tether” the value of the coin to the price of national currencies like the US dollar, the Euro, and the Yen. Like other cryptos it uses blockchain. Unlike other cryptos, it is [according to the official Tether site] “100% backed by USD” (USD is held in reserve). The primary use of Tether is that it offers some stability to the otherwise volatile crypto space and offers liquidity to exchanges who can’t deal in dollars and with banks (for example to the sometimes controversial but leading exchange Bitfinex).  The digital coins are issued by a company called Tether Limited that is governed by the laws of the British Virgin Islands, according to the legal part of its website. It is incorporated in Hong Kong. It has emerged that Jan Ludovicus van der Velde is the CEO of cryptocurrency exchange Bitfinex, which has been accused of being involved in the price manipulation of bitcoin, as well as tether. Many people trading on exchanges, including Bitfinex, will use tether to buy other cryptocurrencies like bitcoin. Tether Limited argues that using this method to buy virtual currencies allows users to move fiat in and out of an exchange more quickly and cheaply. Also, exchanges typically have rocky relationships with banks, and using Tether is a way to circumvent that.  USDT is fairly simple to use. Once on exchanges like Poloniex or Bittrex, it can be used to purchase Bitcoin and other cryptocurrencies. It can be easily transferred from an exchange to any Omni Layer enabled wallet. Tether has no transaction fees, although external wallets and exchanges may charge one. In order to convert USDT to USD and vise versa through the Tether.to Platform, users must pay a small fee. Buying and selling Tether for Bitcoin can be done through a variety of exchanges like the ones mentioned previously or through the Tether.to platform, which also allows the conversion between USD to and from your bank account.

Tether

Tether ($USDT.X) is trending as the crypto community discusses its growing market dominance and potential impact on the broader crypto ecosystem, particularly its relationship with Rumble ($RUM) and other ventures. Concerns around regulatory compliance and transparency, especially with potential new stablecoin legislation, are also driving the conversation. Partnerships, strategic investments, and announcements regarding the launch of the Rumble wallet are additional factors influencing market sentiment.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

FLGC is trending as community members discuss its potential, especially in relation to cannabis rescheduling and the company's crypto holdings. Some are speculating about upcoming revenue and potential for significant gains, while others are focused on compliance with Nasdaq listing standards and possible reverse splits. The stock's low float and recent news regarding funding and private placements are also driving interest.

Hyperliquid is a performant L1 optimized from the ground up. The vision is a fully onchain open financial system with user built applications interfacing with performant native components, all without compromising end user experience.   The Hyperliquid L1 is performant enough to operate an entire ecosystem of permissionless financial applications – every order, cancel, trade, and liquidation happens transparently on-chain with block latency <1 second. The chain currently supports 100k orders / second.  The Hyperliquid L1 uses a custom consensus algorithm called HyperBFT which is heavily inspired by Hotstuff and its successors. Both the algorithm and networking stack are optimized from the ground up to support the L1.   The flagship native application is a fully onchain order book perpetuals exchange, the Hyperliquid DEX. Further developments include a native token standard, spot trading, permissionless liquidity, etc.

Hype

HYPE.X is trending due to its association with the Hyperliquid decentralized exchange, particularly after a mention from CZ (Changpeng Zhao) and Arthur Hayes. The community is actively discussing its potential for further growth and its increasing adoption, especially as it becomes available on more platforms.  Some are also exploring proxy stocks like $HYPD to gain exposure.

Boundless is a universal protocol that brings ZK to every chain. Using Boundless, developers can create expressive, high-throughput applications that bypass traditional block size/gas limits.  Developers submit proof requests and provers compete to fulfill them, earning direct rewards and protocol-level incentives through proof of verifiable work.  By abstracting away the complexity of proof generation, aggregation, and onchain settlement, Boundless allows developers to build without worrying about underlying infrastructure, while provers provide strong liveness guarantees, censorship-resistance, and continuously improve the cost curve driven by open market dynamics.  This architecture decouples execution from consensus and introduces a new paradigm for verifiable computing. As the number of Boundless prover nodes grows, the total capacity of the protocol increases, scaling compute across every chain.

Boundless

Boundless ($ZKC.X) is trending as the community discusses its potential for significant gains and its technology scaling blockchain to the internet. Investors are highlighting its strong onchain documentation and see current awareness levels as an opportunity for accumulation. The token is also drawing comparisons to other cryptocurrencies, with some anticipating substantial growth.

VanEck ETF Trust - VanEck Junior Gold Miners ETF

VanEck Junior Gold Miners ETF

GDXJ is trending as gold prices surge, prompting discussions about potential breakouts and continued rallies. Community members are analyzing technical indicators and debating whether junior gold miners will outperform, while also noting the influence of central bank actions and global economic factors. Many are focused on key support levels and upside targets, weighing both bullish and bearish scenarios for the ETF.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

DXCM is trending due to a short report alleging safety issues with its G7 glucose monitor, sparking community debate about the device's accuracy and reliability, with some users reporting serious health consequences. The report has intensified existing concerns around the G7's performance, overshadowing positive aspects like its smaller size and quick warm-up time. Investors are closely watching for an official response from Dexcom amid concerns about potential market share impact and increased competition.

Based Chad

Based Chad is trending as the community rallies around its strong meme presence and potential integration with the Coinbase DEX.  Enthusiasts are excited about the upcoming Base airdrop, where they believe holding Chad tokens will be rewarded.  Broader discussions highlight the token's solid community and upcoming AAA video game.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates

Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of -45.45% and +9.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Earnings Outlook For Tarsus Pharmaceuticals

Analyst Ratings For Tarsus Pharmaceuticals

Latest Ratings for TARS
 DateFirmActionFromTo Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Nov 2021OppenheimerInitiates Coverage OnOutperform Oct 2021Raymond JamesMaintainsStrong Buy...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $48.38 Average PT from Analysts

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eight research firms that are presently covering the stock, MarketBeat...

Insider Selling: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) General Counsel Sells $135,741.60 in Stock

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS  Get Free Report) General Counsel Bryan Wahl sold 4,436 shares of the firms stock in a transaction dated Monday, March 18th. The stock was sold...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) COO Sells $149,297.40 in Stock

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS  Get Free Report) COO Seshadri Neervannan sold 4,879 shares of the companys stock in a transaction dated Monday, March 18th. The shares were...

Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 6.9%

Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS  Get Free Report) rose 6.9% on Friday . The stock traded as high as $31.73 and last traded at $31.47. Approximately 103,785 shares changed...

Tarsus Pharmaceuticals (TARS, $30.5) entered Downtrend as Momentum indicator drops below 0 level on Mar 11, 2024

This indicator may be signaling that TARS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name

Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. It is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

Tarsus Pharmaceuticals Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

TARS
Tarsus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TARS News

TARS Tarsus Pharmaceuticals Inc